Role of coenzyme Q10 in heart health
Coenzyme Q10 heart health heart failure evidence guideline 2025
"coenzyme Q10" AND "heart failure"
PMID: 39462324
PMID: 39049769
Blueberry on cardiac health and diabetic health
blueberry consumption cardiometabolic health type 2 diabetes systematic review randomized trial 2024 2025
blueberry AND diabetes
blueberry AND cardiovascular
PMID: 38887319
PMID: 37963472
https://pmc.ncbi.nlm.nih.gov/articles/PMC13450227
blueberry AND glycemic control
Role of nitroglycerin in CAD
nitroglycerin chronic coronary disease guideline angina acute coronary syndrome contraindications 2025
nitroglycerin AND stable angina
https://pubmed.ncbi.nlm.nih.gov/35847764
https://www.acc.org/Latest-in-Cardiology/Guidelines/Guidelin…
| Situation | Role of nitroglycerin |
|---|---|
| Stable angina episode | Sublingual tablet or spray provides rapid symptom relief. |
| Before predictable exertion | May be taken prophylactically when prescribed, for example before exercise that usually provokes angina. |
| Persistent acute ischemic pain / acute coronary syndrome | Often used in monitored clinical care, especially when pain persists or blood pressure is elevated, provided there are no contraindications. |
| Vasospastic angina | Relieves acute spasm; longer-acting nitrates may be an add-on preventive therapy, commonly with calcium-channel blockers. |
| Long-term angina prevention | Longer-acting nitrate preparations can reduce symptoms, but tolerance limits continuous use. |
Fruits/vegetables/diets being studied for significantly reducing plaques in coronary arteries
coronary plaque regression dietary intervention Mediterranean vegan portfolio diet randomized trial coronary CT angiography
"coronary plaque" AND diet
"coronary atherosclerosis" AND lifestyle
PMID: 33341413
PMID: 25465939
"coronary atherosclerosis" AND "vegetarian diet"
https://pubmed.ncbi.nlm.nih.gov/33341413
PMID: 1973470
PMID: 37490288
PMID: 39870207
"Mediterranean diet" AND coronary atherosclerosis
| Diet or program | Evidence related to plaque | What it emphasizes |
|---|---|---|
| Intensive plant-predominant lifestyle program | The classic randomized Lifestyle Heart Trial combined a very-low-fat vegetarian diet, smoking cessation, stress management, and moderate exercise. At 1 year, mean coronary stenosis regressed from 40.0% to 37.8%, while it progressed in usual care. This was a small, older, multi-component trial, so it cannot show that diet alone caused regression. Ornish et al., 1990, PMID: 1973470 | Vegetables, fruits, legumes, whole grains, very low saturated fat, little or no animal fat, plus exercise and stress management. |
| DASH-style diet plus optimal medical therapy | In the randomized DISCO-CT study of 92 people with nonobstructive CAD, structured dietitian-supported DASH intervention plus medical therapy produced a greater reduction in noncalcified coronary plaque than medical therapy alone over about 67 weeks. It slowed progression but did not create dramatic overall plaque-volume regression. Henzel et al., 2021, PMID: 33341413 | Vegetables, fruit, beans, whole grains, nuts, low-fat dairy if desired, low sodium; limited processed meat, refined carbohydrate, and saturated fat. |
| Mediterranean diet | Strong evidence supports fewer cardiovascular events and improved vascular health. In CORDIOPREV, a Mediterranean diet rich in extra-virgin olive oil reduced carotid, not coronary, atherosclerosis progression versus a low-fat diet after long follow-up. Direct proof of major coronary-plaque regression is less established. CORDIOPREV trial, PMID: 34372670 | Vegetables, fruit, legumes, whole grains, nuts, extra-virgin olive oil, fish; limited processed meat, sugary foods, and refined grains. |
| Vegetarian or vegan dietary patterns | These reliably improve drivers of plaque growth. In a meta-analysis of 20 randomized trials among people with or at high risk of CVD, vegetarian diets lowered LDL cholesterol by 6.6 mg/dL, HbA1c by 0.24%, and body weight by 3.4 kg on average. Direct evidence of coronary plaque regression is limited. Wang et al., 2023, PMID: 37490288 | Whole plant foods, with attention to protein, B12, iron, iodine, and omega-3 intake. |
| Portfolio-style cholesterol-lowering diet | Strong evidence for LDL lowering, but not yet strong direct evidence that it substantially reverses coronary plaques on imaging. | Plant sterols, viscous soluble fiber, nuts, soy or other plant protein, and low saturated fat. |
Herbs/ayurvedic plants known to lower ldl and reduce plaques
herbal medicine AND LDL cholesterol
herbal medicine AND atherosclerotic plaque
NCCIH red yeast rice garlic berberine cholesterol safety interactions
PMID: 34071454
PMID: 34252530
"red yeast rice" AND LDL cholesterol
berberine AND LDL cholesterol
PMID: 38794691
PMID: 37183391
| Product | LDL effect in studies | Coronary plaque evidence | Main cautions |
|---|---|---|---|
| Red yeast rice | Largest apparent effect. A 2024 meta-analysis reported average LDL reduction of about 36 mg/dL. | No reliable evidence it regresses coronary plaque or prevents events. | It contains monacolin K, chemically the same as lovastatin. It can cause statin-like muscle injury and liver toxicity, interact with medicines, and products vary greatly in active ingredient and may contain the kidney toxin citrinin. Do not self-combine with a statin. |
| Berberine from barberry, Coptis, or Berberis species | Modest and variable. Meta-analysis of 41 trials: combination products lowered LDL by ~15 mg/dL; berberine alone had an uncertain, smaller LDL effect. | No human coronary plaque-regression proof. | Gastrointestinal upset; may lower glucose and interact with diabetes drugs, ciclosporin and other medicines. Avoid in pregnancy, breastfeeding, and infants. |
| Garlic, Allium sativum | Small LDL reduction. Ayurvedic meta-analysis found about 10 mg/dL LDL reduction. | None for coronary plaque regression. | Can increase bleeding tendency, particularly with aspirin, clopidogrel, warfarin, or other anticoagulants. Supplements vary more than culinary garlic. |
| Guggul, Commiphora mukul | Small to moderate LDL reduction in older, generally small trials, about 19 mg/dL in one Ayurvedic meta-analysis. | None for coronary plaque regression. | Evidence quality and product standardization are limited. It may cause rash, stomach symptoms, headache, and drug interactions. Do not use it instead of a statin. |
| Black cumin / black seed, Nigella sativa | May modestly improve total cholesterol and triglycerides. LDL findings are inconsistent. | None for coronary plaque regression. | May lower glucose or blood pressure. Use caution with diabetes and antihypertensive medicines. |
| Turmeric / curcumin, Curcuma longa | Meta-analyses report lipid improvements, but studies are heterogeneous and supplement formulations differ. | No convincing coronary plaque evidence. | May cause gastrointestinal effects and has antiplatelet activity. Discuss high-dose extracts if using antiplatelets or anticoagulants, or with gallbladder disease. |
| Green tea extract | Small LDL reduction in some meta-analyses. | None for plaque regression. | Concentrated extracts, unlike usual brewed tea, have been linked to liver injury. |
Psyllium husk Best time of intake and does it hamper absorption of good fat also
psyllium AND drug absorption
psyllium husk how to take separate medications 2 hours fat soluble vitamins absorption official guidance
Ecospirin and atorvastatins can be used before meal or after meal
atorvastatin prescribing information with or without food aspirin enteric coated take with food administration
atorvastatin AND food absorption
| Medicine | Before or after meals? | Practical advice |
|---|---|---|
| Ecosprin / aspirin | Preferably after food or with food | This may reduce stomach irritation, nausea, or heartburn. Swallow enteric-coated tablets whole. |
| Atorvastatin tablet | With or without food | Take once daily at a consistent time. Morning or evening is acceptable for atorvastatin. |
Psyllium husk vs a combination of inulin + resistant maltodextrin + partially hydrolysed guar gum in equal amount Which is better and to be more suitable in CAD
psyllium versus inulin resistant maltodextrin partially hydrolyzed guar gum LDL cholesterol systematic review CAD
psyllium AND LDL cholesterol
"partially hydrolyzed guar gum" AND cholesterol
inulin AND LDL cholesterol
PMID: 38688104
PMID: 35837742
PMID: 38309832
resistant maltodextrin AND LDL cholesterol
| Feature | Psyllium husk | Inulin + resistant maltodextrin + PHGG blend |
|---|---|---|
| Main effect | Viscous gel, bile-acid binding, LDL lowering | Fermentation by gut bacteria, prebiotic and bowel-function effects |
| LDL-lowering evidence | Stronger and more consistent | Modest and less certain |
| Best role | LDL reduction, post-meal glucose blunting, constipation or loose stools | Gut microbiome support, stool regularity, better tolerance for some people |
| Gas/bloating | Usually modest, especially if dose increased slowly | More likely, especially because inulin is highly fermentable |
| Medication absorption concern | Yes, separate oral medications | Lower theoretical concern but reasonable to separate from important oral medicines |
| CAD suitability | Preferred fiber supplement | Useful adjunct, but not the first choice solely for LDL/CAD |
Role of oxallic acid in ldl metabolism
oxalate AND LDL cholesterol
oxalate oxalic acid LDL cholesterol metabolism human evidence
Atherosclerotic plaque reduces with statins like atorvastatin
Best stent available in indian market